TAKEDA PHARMACEUTICAL CO LTD

Q4 2023 13F Detailed Holdings

Location
Tokyo, Japan
Holdings as of
12/31/2023
Value ($000)
$327,500
Num holdings
16
Date filed
2/13/2025
Form type
13F-HR
Prev filing
Next filing
2/13/2025
Note
Holdings broken out by “other managers” reported in original SEC filing, see here for holdings aggregated across other managers
Sym Issuer Name Cl CUSIP Value ($000) % Shares Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Takeda Vaccines, Inc. 028-24939